MedTrace Logo

Cognitive Resilience Intervention as a Recovery Therapy for Mental Health

NCT06123442 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-11-14

No results posted yet for this study

Summary

The goal of this randomized controlled trial (RCT) is to develop and test a cognitive resilience intervention (CRI) among selected students who are having problems with anxiety, depression, and suicidal thoughts (psychological distress comorbid with suicidal episodes \[PDSE\]) and to see if it can help lower PDSE among the students who were enrolled. This study will assess the feasibility and acceptability of a CRI among students dealing with anxiety, depression, and suicidal thoughts (psychological distress comorbid with suicidal episodes \[PDSE\]) and determine if it is effective at reducing PDSE among the sampled students using psychological assessment tools. Participants will be exposed to CRI in the experimental group and psychoeducation in the control group. Researchers will compare the experimental group with the control group and infer the difference between these groups both at the pretest and posttest phases, as well as ascertain the feasibility and acceptability of this therapy among selected participants.

Conditions

  • Reduction in Mental Health and Suicide Are the Focus of Interest
  • Four Assessment Time Points Would be Used to Monitor Participants Through a Laid Down Conditions

Interventions

BEHAVIORAL

Cognitive Resilience Intervention

Participants will have 12 weeks to complete the program, and then before the post-assessment, there will be a one-month feedback period \[22\]. This includes twelve components: 1) preliminary routine, 2) significance of knowing yourself, 3) interpreting events and stressors, 4) taking autonomy over events, 5) practicing mindfulness and self-compassion, 6) learning adaptation skills, 7) building connection , 8) purpose in life and personal growth, 9) Regulation and disclosure of emotions, 10) practicing gratitude, and 11) positive Communication both intra and interpersonal, 12) overcoming obstacles and moving forward (in the context of current problems) and the conclusion/retrospection are addressed in 12 sessions while closure and post assessment will be done after a month

Sponsors & Collaborators

  • Universidad Autonoma de Ciudad Juarez

    lead OTHER

Principal Investigators

  • Rotimi Oguntayo, Mphil · Universidad Autonoma de Ciudad Juarez

  • Verónica Portillo-Reyes, PhD · Universidad Autonoma de Ciudad Juarez

  • Gerardo Ochoa Meza, PhD · Universidad Autonoma de Ciudad Juarez

  • Marisela Gutiérrez-Vega, PhD · Universidad Autonoma de Ciudad Juarez

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-13
Primary Completion
2024-08-13
Completion
2024-11-01

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06123442 on ClinicalTrials.gov